Skip to main content

Table 1 Patient allocation in groups of active and placebo probiotic agent

From: Association of a probiotic to a Helicobacter pylorieradication regimen does not increase efficacy or decreases the adverse effects of the treatment: a prospective, randomized, double-blind, placebo-controlled study

  

Active

Placebo

p

N

 

55

52

 

Gender

male

21

19

 
 

female

34

33

0.86

Disease

peptic ulcer*

27

24

 
 

dyspepsia

28

28

0.76

Mean age (years)

 

50.4

48.4

0.78

  1. Pearson Chi-Square.
  2. *29 duodenal 17 gastric 5 gastric + duodenal.